Cybin” or the “
Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced the formation of its Clinical Advisory Board, with the additions of Maurizio Fava, MD, Psychiatrist-in-Chief in the Department of Psychiatry at Massachusetts General Hospital; Lynn Marie Morski, MD, Esq., President of the Psychedelic Medicine Association; and Anthony Back, MD, Professor in the Department of Medicine and Division of Oncology at the University of Washington. The Clinical Advisory Board will be chaired by Alex Belser, PhD, Cybin’s Chief Clinical Officer.
“We are delighted to welcome three accomplished experts in their respective fields to guide the strategic development of Cybin’s clinical programs. Together, Drs. Fava, Morski, and Back add unparalleled clinical expertise and strengthen our position to advance psychedelic therapeutics. Their insights will be especially valuable as we move our development pipeline through clinical trials,” s
Cybin Establishes Clinical Advisory Board of Renowned Physicians, Dr Maurizio Fava, Dr Lynn Marie Morski and Dr Anthony Back
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Cybin Establishes Clinical Advisory Board of Renowned Physicians, Dr Maurizio Fava, Dr Lynn Marie Morski and Dr Anthony Back
financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.